期刊文献+

血管紧张素II和洛沙坦对肝星状细胞合成胶原的影响 被引量:6

Effects of angiotensin II and losartan on collagen synthesis in rat hepatic stellate cells
下载PDF
导出
摘要 目的 :探讨血管紧张素II及其 1型受体 (AT1a)拮抗剂洛沙坦 (losartan) ,对肝星状细胞合成胶原的影响。方法 :①大鼠肝星状细胞的分离、培养及鉴定 ;②在不同浓度的血管紧张素II和洛沙坦作用下 ,采用 [3 H]-脯氨酸掺入释放法分别检测肝星状细胞生成胶原的情况。结果 :①细胞得率为 2× 10 7- 3× 10 7个 /只 ,活力在 95 %以上 ,纯度超过 90 %。②血管紧张素II在浓度为 10 -6mol/L - 10 -10 mol/L时 ,肝星状细胞生成胶原明显增多 (P <0 0 5 ) ;血管紧张素II浓度与胶原量呈正相关 (r=0 96 0 ,P <0 0 1)。洛沙坦在浓度为 10 -6mol/L - 10 -9mol/L时 ,胶原生成量显著减少 (P <0 0 5 ) ;且浓度与胶原生成量呈负相关 (r=- 0 882 ,P <0 0 1)。结论 :血管紧张素II可以促使肝星状细胞产生大量的胶原 ;洛沙坦通过拮抗AT1a后 ,胶原合成量显著减少 ,提示血管紧张素II在促使肝纤维化的发展过程中起着重要的作用 。 AIM: To investigate the effects of angiotensin II (Ang II) and AT_(1a) receptor antagonist (losartan) collagen synthesis in rat hepatic stellate cells (HSCs). METHODS: ① Rat HSCs were isolated, cultured and identified. ② Rat HSCs were incubated in the medium with different concentrations of AngII or losartan, then the quantity of collagen was examined by [~3H]-proline release assay. RESULTS: ① The yield of HSCs was 2×10~7-(3×10~7/per) rat, their viability and purity was more than 95% and 90%, respectively. ② The yield of collagen in HSCs significantly got a rise in a concentration-dependent manner when HSCs were incubated with AngII (10^(-6)mol/L-10^(-10) mol/L) (P<0.05). While HSCs were influenced by the antagonist of AT_(1a) (10^(-6) mol/L-10^(-9) mol/L), the quantity of collagen dropped greatly (P<0.05). CONCLUSIONS: Ang II stimulates HSCs to produce more collagen. Losartan inhibits the cell to synthesize collagen via AT_(1a) receptor (P<0.05). The results indicate that Ang II may play an important role in the development of hepatic fibrosis, and use of AT_(1a) antagonist may offer a new strategy to prevent hepatic fibrosis. [
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第10期1842-1845,共4页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目 (No .39870 331)
关键词 血管紧张素Ⅱ 洛沙坦 肝硬化 Angiotensin II Losartan Liver cirrhosis
  • 相关文献

参考文献15

  • 1Seccia TM, Belloni AS, Kreutz R, et al. Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II[J]. J Am Coll Cardiol, 2003,41(4): 666-673.
  • 2Mastruzzo C, Crimi N, Varcheri C. Role of oxidative stress in pulmonary fibrosis[J]. Monaldi Arch Chest Dis, 2002, 57(3-4): 173-176.
  • 3Geleilete TJ, Melo GC, Costa RS, et al. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin[J]. J Nephrol, 2002, 15(6): 6
  • 4Peng J, Guratz D, Tran V, et al. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis[J]. Circ Res, 2002, 91(12): 1119-1126.
  • 5Agarwal R. Proinflamatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade[J]. Am J Physiol, 2003, 284(4): R863-R869.
  • 6Lacolley P, Safar ME, Lucet B, et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats[J]. J Am Coll Cardiol, 2001, 37(2): 662-667.
  • 7Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells[J]. J Hepatol, 1995, 22(Suppl 2): 28-36.
  • 8Brilla CG, Schencking M, Scheer C. Spironolactone: renaissance of anti-aldosterone therapy in heart failure [J]. Schweiz Rundsch Med Prax, 1997, 86(14): 566-574.
  • 9Sun Y, Ratajska A, Zhou G, et al. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone[J]. J Lab Clin Med, 1993, 122(4): 395-403.
  • 10Molteri A, Moulder JE, Cohen EP, et al. Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker[J]. Exp Biol Med, 2001, 226(11): 1016-1023.

二级参考文献5

共引文献36

同被引文献55

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部